Multiple Sclerosis

Midwest CEPAC
May 23, 2019 9am-5pm CT

Hyatt Regency O’Hare
9300 Bryn Mawr Avenue
Rosemont, IL 60018

The Midwest CEPAC will convene to review ICER's assessment of siponimod (Novartis) for secondary progressive multiple sclerosis.

Key Dates

Associated Materials

10/10/2018 – 10/30/2018
Open Input Period

10/31/2018

10/31/2018

10/31/2018 – 11/20/2018

11/29/2018

01/14/2019
Research Protocol

03/14/2019
Draft Evidence Report

03/14/2019
Draft Voting Questions

03/14/2019 – 04/10/2019
Public Comments

05/02/2019
Evidence Report

05/02/2019
Revised Voting Questions

05/02/2019
Response to Comments

05/23/2019
Meeting Agenda

05/23/2019
Evidence Presentation

06/20/2019
Final Evidence Report and Meeting Summary

06/20/2019
Report-at-a-Glance